KindredBio
Kindred Biosciences Announces COVID-19 Vaccine Manufacturing Agreement with Vaxart
Kindred Biosciences has entered into an agreement with Vaxart for the manufacture of Vaxart’s oral vaccine candidate for COVID-19.
Alpha2EQ Regenerative Therapy Product Available to Equine Veterinarians
Kindred Biosciences and Astaria Global announce an affiliate partnership to market and sell Alpha2EQ Therapy Products.
Zimeta Guidelines for USEF and AQHA Performance Horses
Guidelines for using Zimeta (dipyrone injection) in competitive horses were announced by the USEF and AQHA.
KindredBio and Butterfly Network Partner to Expand Innovative Veterinary Diagnostic Tools and Treatment Options
Butterfly iQ Vet is a single probe, smartphone-connected device that can scan animals of all sizes ranging from dogs and cats to horses.
Kindred Biosciences Receives FDA Approval of Zimeta™ (dipyrone injection) for the Control of Pyrexia in Horses
Zimeta was approved for the control of fever in horses.
KindredBio Results for Equine Gastric Ulcer Pilot Study Treatment
KindredBio announced positive results from its pilot effectiveness study of KIND-014 for the treatment of gastric ulcers in horses.
